I hate cancer. I know several people that are battling cancer, and it’s painful to watch those strong people go through it. I can’t even imagine what it’s like. Anything that helps battle cancer should be put to good use, which includes a healthy regimen of cannabis consumption. The results of a study were released this week that suggest that consuming cannabis can significantly lower the risk of developing bladder cancer. Per the Daily Caller:

Each year, nearly 800,000 people in the United States — most of whom are over 65 years old — suffer a stroke, which is a rapid loss of brain function resulting from a blockage of blood supply. Globally, it is estimated that 15 million people suffer the condition. Of those who suffer strokes, about 140,000 (or 18 percent) die. About 25 percent of stroke victims are under 65 years of age.

Leading causes of strokes include high blood pressure, atherosclerosis, a weak heart, and simply the accumulated wear and tear of age. For those who survive a stroke, symptoms include difficulty speaking or full loss of speech, memory impairments, motor (movement) issues, challenges in writing, and even changes in personality.

As a neuropsychopharmacologist at Imperial College London, I study the impact of drug use on the brain. Like many scientists studying these issues, the results I detect in my lab have direct implications on how we can better equip ourselves as a society to deal with drugs.

Victoria GP aims to challenge some of the stigma around medical marijuana

Medical marijuana can be an effective medication when it is properly prescribed. That's the message a B.C. doctor will be giving his fellow physicians on a cross-country speaking tour this month.

Dr. Dave Hepburn, a general practitioner based in Victoria, told On the Island host Gregor Craigie that he will give talks in B.C., Alberta, Saskatchewan, Ontario and Nova Scotia over a five-week period.

He has been giving similar talks over the past year to a varied audience of general practitioners and specialists, hoping to inform and encourage physicians who may have reservations around prescribing medicinal cannabis.

Pain has reached epidemic proportions in America. Almost a third of the population—100 million people—suffer from chronic pain.The problem is real and can impact many aspects of daily life. To take on chronic pain, you must be willing, as both a healthcare professional and a patient, to keep trying and continue searching for a treatment plan that works. This documentary offers an uplifting overview of the journeys of people dealing with a variety of chronic pain conditions and how they have managed their pain. — Paul Christo, MD, MBA

When you work in healthcare marketing, you know you’ve got a big team of experts right there in the building who are carrying around valuable knowledge that could be turned into great content. But they (understandably) have other priorities.

Doctors are busy. At the end of a long day (or night) of attending to patients and helping ward off illness and death, they don’t have a lot of leftover time or energy. On the one hand, you know your inbound marketing efforts would be much stronger if you could get the medical professionals at your hospital involved in content creation. On the other, you know how hard it can be on them to commit to one more thing.

BETHESDA, Md., Sept. 8, 2015 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) announced today that Israeli patients with a medical cannabis license will now have access to Cannabics Pharmaceutical's cannabis oil Capsules.

Cannabics Pharmaceuticals executed an IP Licensing and Collaboration Agreement in Israel with Bazelet Pharma for the distribution of the Company's medical cannabis capsules in Israel through approved medical cannabis growers and in strict compliance with all laws and regulations in Israel.

From October 1, 2015, patients in Israel with a medical cannabis license shall be entitled to receive Cannabics oil capsules. These capsules are offered in two dosages: 1. Hermon-SR 10mg THC   2. Gilboa-SR 9.5mg THC, 0.5mg CBD.

MEXICO CITY - An eight-year-old girl who endures 400 daily epileptic seizures will become Mexico's first authorized consumer of medical cannabis after the government granted her an exemption to its marijuana ban.

Grace Elizalde, who lives in the northern industrial hub of Monterrey, has a severe form of epilepsy known as the Lennox-Gastaut syndrome

The health ministry announced in a statement that it would facilitate the paperwork needed to import a cannabis oil that is believed to alleviate epileptic fits.

"We are happy," Raul Elizalde, the girl's father, told AFP by telephone after he met with the head of Cofepris, the health agency that oversees medicine imports. "It's our last hope."

Marijuana is the popular name for cannabis, a plant genus that contains three species. Although often highlighted for its controversial use as a recreational drug, cannabis has drawn increasing attention in recent years for its use in a variety of medical conditions.

Cannabis is chemically complex, containing more than 85 substances (cannabinols) that have biological effects. One cannabinol, tetrahydrocannabinol (THC), stimulates specific receptors in the brain to cause a range of effects, including euphoria. THC is the major factor in the recreational use of cannabis; the other cannabinoids have no known psychoactive effects but have been increasingly used in the treatment of disease.